UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A double‐blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitis

Alimentary pharmacology & therapeutics, 2002-01, Vol.16 (1), p.69-77

2002

Volltextzugriff (PDF)

Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis

Gastroenterology (New York, N.Y. 1943), 1998, Vol.114 (1), p.15-22

1998

Volltextzugriff (PDF)

Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months

Alimentary pharmacology & therapeutics, 1998-12, Vol.12 (12), p.1207-1216

1998

Volltextzugriff (PDF)

Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance

Gut, 1992-08, Vol.33 (8), p.1071-1075

1992

Volltextzugriff (PDF)

Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist

Gastroenterology (New York, N.Y. 1943), 1994-03, Vol.106 (3), p.637-642

1994

Volltextzugriff (PDF)

Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease

Gut, 1992-05, Vol.33 (5), p.646-650

1992

Volltextzugriff (PDF)

The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique

Journal of medical microbiology, 1991-10, Vol.35 (4), p.238-243

1991

Volltextzugriff (PDF)

Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohn's disease

Gut, 1995-01, Vol.36 (1), p.60-66

1995

Volltextzugriff (PDF)

Studies on the mechanism of bowel disturbance in ulcerative colitis

Gastroenterology (New York, N.Y. 1943), 1987-11, Vol.93 (5), p.934-940

1987

Volltextzugriff (PDF)

Controlled trial of polymeric versus elemental diet in treatment of active Crohn's disease

The Lancet (British edition), 1990-04, Vol.335 (8693), p.816-819

1990

Volltextzugriff (PDF)

Does Adjuvant Nutritional Support Diminish Steroid Dependency in Crohn Disease?

Scandinavian journal of gastroenterology, 2001-01, Vol.36 (4), p.383-388

2001

Volltextzugriff (PDF)

Clinical tolerance to three 5‐aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazine

Alimentary pharmacology & therapeutics, 1992-02, Vol.6 (1), p.51-59

1992

Volltextzugriff (PDF)

Anorectal sensitivity and responses to rectal distention in patients with ulcerative colitis

Gastroenterology (New York, N.Y. 1943), 1987-12, Vol.93 (6), p.1270-1275

1987

Volltextzugriff (PDF)

Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns

Gut, 1983-05, Vol.24 (5), p.405-411

1983

Volltextzugriff (PDF)

Long‐term effects of elemental and exclusion diets for Crohn's disease

Alimentary pharmacology & therapeutics, 1991-04, Vol.5 (2), p.115-125

1991

Volltextzugriff (PDF)

Does Adjuvant Nutritional Support Diminish Steroid Dependency in Crohn Disease?

Scandinavian journal of gastroenterology, 2001-04, Vol.36 (4), p.383-388

2001

Volltextzugriff (PDF)

What is the benefit of coarse wheat bran in patients with irritable bowel syndrome?

Gut, 1984-02, Vol.25 (2), p.168-173

1984

Volltextzugriff (PDF)

Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study

Gut, 1989-05, Vol.30 (5), p.675-679

1989

Volltextzugriff (PDF)

Quantitative assessment of overall inflammatory bowel disease activity using labelled leucocytes: a direct comparison between indium-111 and technetium-99m HMPAO methods

Gut, 1995-11, Vol.37 (5), p.679-683

1995

Volltextzugriff (PDF)

Improved maintenance of remission in ulcerative colitis by balsalazide 4 g/day compared with 2 g/day

Alimentary pharmacology & therapeutics, 1992-08, Vol.6 (4), p.479-485

1992

Volltextzugriff (PDF)

Symptoms and stool patterns in patients with ulcerative colitis

Gut, 1988-03, Vol.29 (3), p.342-345

1988

Volltextzugriff (PDF)

Role of loperamide and placebo in management of irritable bowel syndrome (IBS)

Digestive diseases and sciences, 1984-03, Vol.29 (3), p.239-247

1984

Volltextzugriff (PDF)

Effect of L-arginine on intestinal water and sodium absorption

Gut, 1997-12, Vol.41 (6), p.860-860

1997

Volltextzugriff (PDF)

Double blind trial of oral fluticasone propionate v prednisolone in the treatment of active ulcerative colitis

Gut, 1993-01, Vol.34 (1), p.125-128

1993

Volltextzugriff (PDF)

Anorectal contractility under basal conditions and during rectal infusion of saline in ulcerative colitis

Gut, 1988-06, Vol.29 (6), p.769-777

1988

Volltextzugriff (PDF)

1 – 25 von 489

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(451)
Mit Volltextzugriff
(384)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A double‐blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitis

Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis

Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months

Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance

Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist

Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease

The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique

Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohn's disease

Studies on the mechanism of bowel disturbance in ulcerative colitis

Controlled trial of polymeric versus elemental diet in treatment of active Crohn's disease

Does Adjuvant Nutritional Support Diminish Steroid Dependency in Crohn Disease?

Clinical tolerance to three 5‐aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazine

Anorectal sensitivity and responses to rectal distention in patients with ulcerative colitis

Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns

Long‐term effects of elemental and exclusion diets for Crohn's disease

Does Adjuvant Nutritional Support Diminish Steroid Dependency in Crohn Disease?

What is the benefit of coarse wheat bran in patients with irritable bowel syndrome?

Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study

Quantitative assessment of overall inflammatory bowel disease activity using labelled leucocytes: a direct comparison between indium-111 and technetium-99m HMPAO methods

Improved maintenance of remission in ulcerative colitis by balsalazide 4 g/day compared with 2 g/day

Symptoms and stool patterns in patients with ulcerative colitis

Role of loperamide and placebo in management of irritable bowel syndrome (IBS)

Effect of L-arginine on intestinal water and sodium absorption

Double blind trial of oral fluticasone propionate v prednisolone in the treatment of active ulcerative colitis

Anorectal contractility under basal conditions and during rectal infusion of saline in ulcerative colitis

Suchergebnisse filtern